CPH 0.00% 0.9¢ creso pharma limited

Creso’s acquisition target Halucenex to extend clinical trials beyond veterans

  1. 184 Posts.
    lightbulb Created with Sketch. 13
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.